Company Profile:
GLENMARK LIFE SCIENCES LTD INDIA is a manufacturer.
Company Introduction:
GLENMARK LIFE SCIENCES LTD INDIA is a prominent developer and manufacturer of Active Pharmaceutical Ingredients (APIs), intermediates, and provides Contract Development and Manufacturing Organization (CDMO) services. The company was demerged from Glenmark Pharmaceuticals Ltd. to focus exclusively on the API business.
Glenmark Life Sciences specializes in manufacturing high-value, non-commoditized APIs across various therapeutic areas, including cardiovascular diseases, central nervous system disorders, pain management, anti-infectives, and oncology. They leverage strong research and development capabilities to innovate and produce complex molecules.
The company operates multiple state-of-the-art manufacturing facilities in India, which are compliant with global regulatory standards, including those of the US FDA, European regulatory authorities, and others. Their business model emphasizes quality, regulatory adherence, and a robust supply chain to serve pharmaceutical companies worldwide.
Enterprise Products
GLENMARK LIFE SCIENCES LTD INDIA primarily manufactures and sells Active Pharmaceutical Ingredients (APIs) and offers Contract Development and Manufacturing Organization (CDMO) services.
Products Manufactured or Sold:
1. Active Pharmaceutical Ingredients (APIs)
These are the key chemical components that provide therapeutic effects in pharmaceutical drugs. Glenmark Life Sciences produces a wide range of APIs across various therapeutic areas, including:
* Anti-neoplastic (Oncology)
* Anti-coagulant
* Anti-diabetic
* Central Nervous System (CNS) disorders
* Anti-inflammatory
* Cardiovascular
* Anti-infective
* Anti-histamine
* Anti-fungal
* Anti-viral
* Gastrointestinal
Examples of specific APIs they produce include: Perindopril Erbumine, Telmisartan, Rosuvastatin Calcium, Atorvastatin Calcium, Ezetimibe, Rivaroxaban, Apixaban, Dabigatran Etexilate, Teneligliptin, Vildagliptin, Saxagliptin, Sitagliptin, Remogliflozin Etabonate, Empagliflozin, Dapagliflozin, Tacrolimus, Mycophenolate Mofetil, Mycophenolic Acid Sodium, Mirtazapine, Aripiprazole, Olanzapine, Quetiapine Fumarate, Paliperidone, Linezolid, Posaconazole, Isavuconazonium Sulfate, Voriconazole, Clevudine, Lamivudine, Tenofovir Disoproxil Fumarate, Dolutegravir Sodium, Bictegravir, Entecavir.
2. Contract Development and Manufacturing Organization (CDMO) Services
Glenmark Life Sciences provides integrated services for the development and manufacturing of Active Pharmaceutical Ingredients (APIs) for innovator pharmaceutical companies. These services cover various stages from early-stage development to commercial-scale production, including process development, scale-up, and regulatory support.